News
Oppenheimer Maintains Outperform on Corvus Pharma, Raises Price Target to $8
7 May 24
News, Price Target, Analyst Ratings
Corvus Pharma Q1 2024 GAAP EPS $(0.12), Inline
6 May 24
Earnings, News
Corvus Pharmaceuticals Announces Pricing Of $30.6M Registered Direct Offering
2 May 24
News, Offerings
12 Health Care Stocks Moving In Tuesday's After-Market Session
9 Apr 24
Movers
Corvus Pharmaceuticals Announces Initiation Of Placebo-Controlled Phase 1 Clinical Trial Of Soquelitinib For Atopic Dermatitis
9 Apr 24
Biotech, News, General
Cantor Fitzgerald Reiterates Overweight on Corvus Pharma
1 Apr 24
News, Reiteration, Analyst Ratings
Mizuho Maintains Neutral on Corvus Pharma, Maintains $3.5 Price Target
27 Mar 24
News, Price Target, Analyst Ratings
Oppenheimer Maintains Outperform on Corvus Pharma, Lowers Price Target to $7
20 Mar 24
News, Price Target, Analyst Ratings
Earnings Outlook For Corvus Pharma
18 Mar 24
Earnings
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data At Keystone Symposia On Systemic Autoimmune and Autoinflammatory Diseases
12 Feb 24
Biotech, News, General
Press releases
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
6 May 24
Earnings, Press Releases
Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024
2 May 24
News, Press Releases
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering
2 May 24
Press Releases
Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
9 Apr 24
Press Releases
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024
13 Mar 24
News, Health Care, Press Releases
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases
12 Feb 24
News, Health Care, Press Releases